← FDA Drug Approvals (Drugs@FDA)

TAZAROTENE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMA CANADA · Approved 2017-04-03

Drug application

FDA Application #

ANDA208258

Application type

Abbreviated New Drug Application (Generic)

Brand name

TAZAROTENE

Generic name

TAZAROTENE

Active ingredients

TAZAROTENE

Dosage form

CREAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

SUN PHARMA CANADA

Manufacturer

Sun Pharmaceutical Industries, Inc.

First approval

2017-04-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown